Balancing key stakeholder priorities and ethical principles to design a trial comparing intervention or expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy: FERN qualitative study
BMJ Open · 2024-08 · 14 (8) · e080488
DOI: 10.1136/bmjopen-2023-080488 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift BMJ Open, online erschienen am 09.08.2024. Verfasst von Tracy Karen Mitchell und 11 weiteren Autor:innen. Beteiligte Einrichtung: Public Health, Policy and Systems, University of Liverpool, Liverpool, UK Tracy.Mitchell@Liverpool.ac.uk. Hauptthemen laut MEDLINE: Pregnancy, Twin, Fetal Growth Retardation, Qualitative Research. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment Programme.
Abstract (Originalsprache)
Objectives
As part of the FERN feasibility study, this qualitative research aimed to explore parents’ and clinicians’ views on the acceptability, feasibility and design of a randomised controlled trial (RCT) of active intervention versus expectant management in monochorionic (MC) diamniotic twin pregnancies with early-onset (prior to 24 weeks) selective fetal growth restriction (sFGR). Interventions could include laser treatment or selective termination which could lead to the death or serious disability of one or both twins.
Design
Qualitative semi-structured interviews with parents and clinicians. Data were analysed using reflexive thematic analysis and considered against the Principles of Biomedical Ethics. Participants and setting We interviewed 19 UK parents experiencing (six mothers, two partners) or had recently experienced (eight mothers, three partners) early-onset sFGR in MC twin pregnancy and 14 specialist clinicians from the UK and Europe.
Results
Participants viewed the proposed RCT as ‘ethically murky’ because they believed that the management of sFGR in MC twin pregnancy should be individualised according to the type and severity of sFGR. Clinicians prioritised the gestational age, size, decrease in growth velocity, access to the placental vessels and acceptability of intervention for parents. Discussions and decision-making about selective termination appeared to cause long-term harm (maleficence). The most important outcome for parents and clinicians was ‘live birth’. For clinicians, this was the live birth of at least one twin. For parents, this meant the live birth of both twins, even if this meant that their babies had neurodevelopmental impairment or disabilities.
Conclusions
All three pregnancy management approaches for sFGR in MC twin pregnancy carry risks and benefits, and the ultimate goal for parents is to receive individualised care to achieve the best possible outcome for both twins. An RCT was not acceptable to parents or clinicians or seen as ethically appropriate. Alternative study designs should be considered to answer this important research question.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Public Health, Policy and Systems, University of Liverpool, Liverpool, UK Tracy.Mitchell@Liverpool.ac.uk.
- Public Health, Policy and Systems, University of Liverpool, Liverpool, UK.
- School of Law, City University of London, London, UK.
- Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.
- Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
- Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
ORCID-Profile: Tracy Karen Mitchell, Mariana Popa, Richard Edmund Ashcroft, Smriti Prasad, Andrew Sharp, Mark Turner, Asma Khalil, Natasha Fenwick, Kerry Woolfall
Förderung
- Health Technology Assessment Programme
Zitieren
APA
Mitchell, T. K., Popa, M., Ashcroft, R. E., Prasad, S., Sharp, A., Carnforth, C., Turner, M., Khalil, A., Fenwick, N., Leven, S., FERN study team, & Woolfall, K. (2024). Balancing key stakeholder priorities and ethical principles to design a trial comparing intervention or expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy: FERN qualitative study. BMJ Open, 14(8), e080488. https://doi.org/10.1136/bmjopen-2023-080488
Vancouver
Mitchell TK, Popa M, Ashcroft RE, Prasad S, Sharp A, Carnforth C, et al. Balancing key stakeholder priorities and ethical principles to design a trial comparing intervention or expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy: FERN qualitative study. BMJ Open. 2024;14(8):e080488. doi:10.1136/bmjopen-2023-080488
BibTeX
@article{Mitchell2024,
author = {Mitchell, Tracy Karen and Popa, Mariana and Ashcroft, Richard Edmund and Prasad, Smriti and Sharp, Andrew and Carnforth, Christine and Turner, Mark and Khalil, Asma and Fenwick, Natasha and Leven, Shauna and FERN study team, FERN study team and Woolfall, Kerry},
title = {Balancing key stakeholder priorities and ethical principles to design a trial comparing intervention or expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy: FERN qualitative study},
journal = {BMJ Open},
year = {2024},
volume = {14},
number = {8},
pages = {e080488},
doi = {10.1136/bmjopen-2023-080488}
}
EUVIMED